BCR::ABL1 transcripts and clinical outcome - interrogating the technique

dc.contributor.authorBranford, S.
dc.date.issued2022
dc.descriptionCommentary on: Dominy et al., Assessment of quantitative PCR for BCR::ABL1 Transcripts in CML: are improved outcomes in patients with e14a2 transcripts an artefact of technology
dc.description.abstractAbstract not available
dc.description.statementofresponsibilitySusan Branford
dc.identifier.citationBritish Journal of Haematology, 2022; 197(1):9-10
dc.identifier.doi10.1111/bjh.18046
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.orcidBranford, S. [0000-0002-1964-3626] [0000-0002-5095-7981]
dc.identifier.urihttps://hdl.handle.net/2440/134434
dc.language.isoen
dc.publisherWiley
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1117718
dc.rights© 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
dc.source.urihttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.18046
dc.subjectchronic myeloid-leukemia
dc.subjectBCR::ABL1
dc.titleBCR::ABL1 transcripts and clinical outcome - interrogating the technique
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_134434.pdf
Size:
140.11 KB
Format:
Adobe Portable Document Format
Description:
Published version